-
2
-
-
0036063208
-
The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: A systematic review of randomized placebo-controlled trials
-
Alsaeedi A, Sin DD, McAlister FA. The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials. Am J Med 2002;113:59-65.
-
(2002)
Am J Med
, vol.113
, pp. 59-65
-
-
Alsaeedi, A.1
Sin, D.D.2
McAlister, F.A.3
-
3
-
-
33646368915
-
Statistical treatment of exacerbations in therapeutic trials of chronic obstructive pulmonary disease
-
Suissa S. Statistical treatment of exacerbations in therapeutic trials of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;173:842-846.
-
(2006)
Am J Respir Crit Care Med
, vol.173
, pp. 842-846
-
-
Suissa, S.1
-
4
-
-
33847172367
-
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease
-
Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007;356:775-789.
-
(2007)
N Engl J Med
, vol.356
, pp. 775-789
-
-
Calverley, P.M.1
Anderson, J.A.2
Celli, B.3
Ferguson, G.T.4
Jenkins, C.5
Jones, P.W.6
Yates, J.C.7
Vestbo, J.8
-
5
-
-
0037764092
-
COPD exacerbations: Definitions and classifications
-
s
-
Burge S, Wedzicha JA. COPD exacerbations: definitions and classifications. Eur Respir J Suppl 2003;41:46s-53s.
-
(2003)
Eur Respir J Suppl
, vol.41
-
-
Burge, S.1
Wedzicha, J.A.2
-
6
-
-
24644492301
-
Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: A randomized trial
-
Niewoehner DE, Rice K, Cote C, Paulson D, Cooper JA Jr, Korducki L, Cassino C, Kesten S. Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial. Ann Intern Med 2005;143:317-326.
-
(2005)
Ann Intern Med
, vol.143
, pp. 317-326
-
-
Niewoehner, D.E.1
Rice, K.2
Cote, C.3
Paulson, D.4
Cooper Jr, J.A.5
Korducki, L.6
Cassino, C.7
Kesten, S.8
-
7
-
-
0026697298
-
Acetylcholine stimulates bronchial epithelial cells to release neutrophil and monocyte chemotactic activity
-
Koyama S, Rennard SI, Robbins RA. Acetylcholine stimulates bronchial epithelial cells to release neutrophil and monocyte chemotactic activity. Am J Physiol 1992;262:L466-L471.
-
(1992)
Am J Physiol
, vol.262
-
-
Koyama, S.1
Rennard, S.I.2
Robbins, R.A.3
-
8
-
-
0037470634
-
The presence and functions of muscarinic receptors in human T cells: The involvement in IL-2 and IL-2 receptor system
-
Nomura J, Hosoi T, Okuma Y, Nomura Y. The presence and functions of muscarinic receptors in human T cells: the involvement in IL-2 and IL-2 receptor system. Life Sci 2003;72:2121-2126.
-
(2003)
Life Sci
, vol.72
, pp. 2121-2126
-
-
Nomura, J.1
Hosoi, T.2
Okuma, Y.3
Nomura, Y.4
-
9
-
-
0034890383
-
Alternative mechanisms for long-acting beta(2)-adrenergic agonists in COPD
-
Johnson M, Rennard S. Alternative mechanisms for long-acting beta(2)-adrenergic agonists in COPD. Chest 2001;120:258-270.
-
(2001)
Chest
, vol.120
, pp. 258-270
-
-
Johnson, M.1
Rennard, S.2
-
10
-
-
0034901163
-
Effects of formoterol and budesonide on GM-CSF and IL-8 secretion by triggered human bronchial epithelial cells
-
Korn SH, Jerre A, Brattsand R. Effects of formoterol and budesonide on GM-CSF and IL-8 secretion by triggered human bronchial epithelial cells. Eur Respir J 2001;17:1070-1077.
-
(2001)
Eur Respir J
, vol.17
, pp. 1070-1077
-
-
Korn, S.H.1
Jerre, A.2
Brattsand, R.3
-
11
-
-
0036191465
-
Additive anti-inflammatory effect of formoterol and budesonide on human lung fibroblasts
-
Spoelstra FM, Postma DS, Hovenga H, Noordhoek JA, Kauffman HF. Additive anti-inflammatory effect of formoterol and budesonide on human lung fibroblasts. Thorax 2002;57:237-241.
-
(2002)
Thorax
, vol.57
, pp. 237-241
-
-
Spoelstra, F.M.1
Postma, D.S.2
Hovenga, H.3
Noordhoek, J.A.4
Kauffman, H.F.5
-
12
-
-
33645304010
-
Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease
-
Barnes NC, Qiu YS, Pavord ID, Parker D, Davis PA, Zhu J, Johnson M, Thomson NC, Jeffery PK. Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease. Am J Respir Crit Care Med 2006;173:736-743.
-
(2006)
Am J Respir Crit Care Med
, vol.173
, pp. 736-743
-
-
Barnes, N.C.1
Qiu, Y.S.2
Pavord, I.D.3
Parker, D.4
Davis, P.A.5
Zhu, J.6
Johnson, M.7
Thomson, N.C.8
Jeffery, P.K.9
-
13
-
-
0038075468
-
A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema
-
Fishman A, Martinez F, Naunheim K, Piantadosi S, Wise R, Ries A, Weinmann G, Wood DE. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003;348:2059-2073.
-
(2003)
N Engl J Med
, vol.348
, pp. 2059-2073
-
-
Fishman, A.1
Martinez, F.2
Naunheim, K.3
Piantadosi, S.4
Wise, R.5
Ries, A.6
Weinmann, G.7
Wood, D.E.8
-
14
-
-
38349061168
-
The effect of lung volume reduction surgery on acute exacerbations of chronic obstructive pulmonary disease [abstract]
-
for the NETT Research Group
-
Washko G, Fan VS, Ramsey SD, Reilly JJ, for the NETT Research Group. The effect of lung volume reduction surgery on acute exacerbations of chronic obstructive pulmonary disease [abstract]. Am J Respir Crit Care Med 2007;175:A812.
-
(2007)
Am J Respir Crit Care Med
, vol.175
-
-
Washko, G.1
Fan, V.S.2
Ramsey, S.D.3
Reilly, J.J.4
-
15
-
-
0032886295
-
Rationale and design of the National Emphysema Treatment Trial (NETT): A prospective randomized trial of lung volume reduction surgery
-
National Emphysema Treatment Trial Research Group
-
National Emphysema Treatment Trial Research Group. Rationale and design of the National Emphysema Treatment Trial (NETT): a prospective randomized trial of lung volume reduction surgery. J Thorac Cardiovasc Surg 1999;118:518-528.
-
(1999)
J Thorac Cardiovasc Surg
, vol.118
, pp. 518-528
-
-
-
16
-
-
0035104977
-
Economic analysis of lung volume reduction surgery as part of the National Emphysema Treatment Trial. NETT Research Group
-
Ramsey SD, Sullivan SD, Kaplan RM, Wood DE, Chiang YP, Wagner JL. Economic analysis of lung volume reduction surgery as part of the National Emphysema Treatment Trial. NETT Research Group. Ann Thorac Surg 2001;71:995-1002.
-
(2001)
Ann Thorac Surg
, vol.71
, pp. 995-1002
-
-
Ramsey, S.D.1
Sullivan, S.D.2
Kaplan, R.M.3
Wood, D.E.4
Chiang, Y.P.5
Wagner, J.L.6
-
17
-
-
33847365003
-
Physiologic variables and functional status independently predict COPD hospitalizations and emergency department visits in patients with severe COPD
-
Fan VS, Ramsey SD, Make BJ, Martinez FJ. Physiologic variables and functional status independently predict COPD hospitalizations and emergency department visits in patients with severe COPD. COPD 2007;4:29-39.
-
(2007)
COPD
, vol.4
, pp. 29-39
-
-
Fan, V.S.1
Ramsey, S.D.2
Make, B.J.3
Martinez, F.J.4
-
18
-
-
0029585491
-
Validity of the recording of ischaemic heart disease and chronic obstructive pulmonary disease in the Saskatchewan health care datafiles
-
Rawson NS, Malcolm E. Validity of the recording of ischaemic heart disease and chronic obstructive pulmonary disease in the Saskatchewan health care datafiles. Stat Med 1995;14:2627-2643.
-
(1995)
Stat Med
, vol.14
, pp. 2627-2643
-
-
Rawson, N.S.1
Malcolm, E.2
-
19
-
-
0023092594
-
A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
-
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383.
-
(1987)
J Chronic Dis
, vol.40
, pp. 373-383
-
-
Charlson, M.E.1
Pompei, P.2
Ales, K.L.3
MacKenzie, C.R.4
-
20
-
-
0026639706
-
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
-
Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-619.
-
(1992)
J Clin Epidemiol
, vol.45
, pp. 613-619
-
-
Deyo, R.A.1
Cherkin, D.C.2
Ciol, M.A.3
-
21
-
-
0035846315
-
Patients at high risk of death after lung-volume-reduction surgery
-
National Emphysema Treatment Trial Research Group
-
National Emphysema Treatment Trial Research Group. Patients at high risk of death after lung-volume-reduction surgery. N Engl J Med 2001;345:1075-1083.
-
(2001)
N Engl J Med
, vol.345
, pp. 1075-1083
-
-
-
22
-
-
0029982081
-
Improvement in pulmonary function and elastic recoil after lung-reduction surgery for diffuse emphysema
-
Sciurba FC, Rogers RM, Keenan RJ, Slivka WA, Gorcsan J III, Ferson PF, Holbert JM, Brown ML, Landreneau RJ. Improvement in pulmonary function and elastic recoil after lung-reduction surgery for diffuse emphysema. N Engl J Med 1996;334:1095-1099.
-
(1996)
N Engl J Med
, vol.334
, pp. 1095-1099
-
-
Sciurba, F.C.1
Rogers, R.M.2
Keenan, R.J.3
Slivka, W.A.4
Gorcsan III, J.5
Ferson, P.F.6
Holbert, J.M.7
Brown, M.L.8
Landreneau, R.J.9
-
24
-
-
0014375143
-
Effect of removal of bullae on airway conductance and conductance volume ratios
-
Rogers RM, DuBois AB, Blakemore WS. Effect of removal of bullae on airway conductance and conductance volume ratios. J Clin Invest 1968;47:2569-2579.
-
(1968)
J Clin Invest
, vol.47
, pp. 2569-2579
-
-
Rogers, R.M.1
DuBois, A.B.2
Blakemore, W.S.3
-
25
-
-
0037425745
-
Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: A randomised controlled trial
-
Calverley P, Pauwels R, Vestbo J, Jones P, Pride N, Gulsvik A, Anderson J, Maden C. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2003;361:449-456.
-
(2003)
Lancet
, vol.361
, pp. 449-456
-
-
Calverley, P.1
Pauwels, R.2
Vestbo, J.3
Jones, P.4
Pride, N.5
Gulsvik, A.6
Anderson, J.7
Maden, C.8
|